Remove 2019 Remove Epilepsy Remove Treatment
article thumbnail

IDPH approves four new conditions for medical cannabis treatment

Illinois News Joint

Providers are now able to begin certifying patients with those conditions for treatment with medical cannabis. The four approvals mark the first expansion of the list of conditions that can be treated with medical cannabis since 2019. Those four newly added conditions bring the total to 56. For Illinois News Joint reviews, visit here.

article thumbnail

A New Treatment: CBD Oil For Autism?

Puff Puff Post

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. As it sits, only a few methods of treating autism are available.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Serious Conditions Are Responding To Cannabinoid Therapy

Peninsula Alternative Health

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

article thumbnail

UK’s MS Society Launches #ApprovedButDenied Campaign

Veriheal

Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? 1, MS Society UK posted on Twitter , “Getting the treatment you need shouldn’t be a game of chance. It’s this line of thought that contributed to the drive for launching a campaign. . ApprovedButDenied.

article thumbnail

Cannabis Patents are Approaching the Patent Trial and Appeal Board

Canna Law Blog

On January 3, 2019, the PTAB published its Final Written Decision in the case, Insys Development Co, Inc. 9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). We’ll know whether either side appeals the Final Written Decision by March 8, 2019.

article thumbnail

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Why Do MMJ Patients Use Cannabis?

Access 98
article thumbnail

What is CBD? Everything you need to know

The Cannigma

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122